A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease

Clinical trial NCT06984627 · RECRUITING

Trial details

NCT number: NCT06984627
Sponsor: Sanofi
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Graves' Disease

Start date: 2025-09-02
Primary completion: 2026-08-25
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.